These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 33442767)

  • 1. Pragmatic trials, blinding, placebos, and the usefulness of the PRECIS-2 tool.
    Dal-Ré R
    Eur J Clin Pharmacol; 2021 Jul; 77(7):1071-1072. PubMed ID: 33442767
    [No Abstract]   [Full Text] [Related]  

  • 2. Blinding, pragmatism, and the PRECIS-2 tool for designing and assessing randomized trials.
    Zwarenstein M; Howie A
    Eur J Clin Pharmacol; 2021 Jul; 77(7):1069-1070. PubMed ID: 33394054
    [No Abstract]   [Full Text] [Related]  

  • 3. The landscape and lexicon of blinding in randomized trials.
    Schulz KF; Chalmers I; Altman DG
    Ann Intern Med; 2002 Feb; 136(3):254-9. PubMed ID: 11827510
    [No Abstract]   [Full Text] [Related]  

  • 4. The design can limit PRECIS-2 retrospective assessment of the clinical trial explanatory/pragmatic features.
    Dal-Ré R; de Boer A; James SK
    J Clin Epidemiol; 2020 Oct; 126():193-201. PubMed ID: 32325221
    [No Abstract]   [Full Text] [Related]  

  • 5. In the dark: the reporting of blinding status in randomized controlled trials.
    Montori VM; Bhandari M; Devereaux PJ; Manns BJ; Ghali WA; Guyatt GH
    J Clin Epidemiol; 2002 Aug; 55(8):787-90. PubMed ID: 12384193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The blind leading the blind: use and misuse of blinding in randomized controlled trials.
    Miller LE; Stewart ME
    Contemp Clin Trials; 2011 Mar; 32(2):240-3. PubMed ID: 21070890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing blinding in randomised controlled trials of acupuncture: challenges and recommendations.
    Hopton AK; Macpherson H
    Chin J Integr Med; 2011 Mar; 17(3):173-6. PubMed ID: 21359917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Roaming through methodology. XXIII. The need for randomization and blinding in therapeutic investigations].
    Dorhout Mees EJ
    Ned Tijdschr Geneeskd; 2000 Nov; 144(46):2228. PubMed ID: 11103264
    [No Abstract]   [Full Text] [Related]  

  • 9. Blinding in placebo-controlled trials.
    Ehrlich GE
    Ann Intern Med; 2001 Jun; 134(12):1150-1. PubMed ID: 11412060
    [No Abstract]   [Full Text] [Related]  

  • 10. Blinding in placebo-controlled trials.
    Prasad AS
    Ann Intern Med; 2001 Jun; 134(12):1150; discussion 1151. PubMed ID: 11412059
    [No Abstract]   [Full Text] [Related]  

  • 11. Who is blinded in randomized clinical trials? A study of 200 trials and a survey of authors.
    Haahr MT; Hróbjartsson A
    Clin Trials; 2006; 3(4):360-5. PubMed ID: 17060210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The reporting of blinding in orthodontic randomized controlled trials: where do we stand?
    Abdulraheem S; Bondemark L
    Eur J Orthod; 2019 Jan; 41(1):54-58. PubMed ID: 29697755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How well does blinding work in randomized controlled trials?: a counterpoint.
    Boehmer J; Yong P
    Clin Pharmacol Ther; 2009 May; 85(5):463-5. PubMed ID: 19381149
    [No Abstract]   [Full Text] [Related]  

  • 14. Blinding in pharmaceutical clinical trials: An overview of points to consider.
    Crisp A
    Contemp Clin Trials; 2015 Jul; 43():155-63. PubMed ID: 26044462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blinding during data analysis and writing of manuscripts.
    Gøtzsche PC
    Control Clin Trials; 1996 Aug; 17(4):285-90; discussion 290-3. PubMed ID: 8889343
    [No Abstract]   [Full Text] [Related]  

  • 16. Blinding in psychotherapy plus medication trials.
    Smith EG; Mathur A
    Am J Psychiatry; 2006 Jul; 163(7):1295. PubMed ID: 16816244
    [No Abstract]   [Full Text] [Related]  

  • 17. The attractiveness of the concept of a prospectively designed two-stage clinical trial.
    Chi GY; Liu Q
    J Biopharm Stat; 1999 Nov; 9(4):537-47. PubMed ID: 10576402
    [No Abstract]   [Full Text] [Related]  

  • 18. Specific instructions for estimating unclearly reported blinding status in randomized trials were reliable and valid.
    Akl EA; Sun X; Busse JW; Johnston BC; Briel M; Mulla S; You JJ; Bassler D; Lamontagne F; Vera C; Alshurafa M; Katsios CM; Heels-Ansdell D; Zhou Q; Mills E; Guyatt GH
    J Clin Epidemiol; 2012 Mar; 65(3):262-7. PubMed ID: 22200346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blinding in RCTs.
    El-Masri MM
    Can Nurse; 2015 Mar; 111(2):9. PubMed ID: 26387218
    [No Abstract]   [Full Text] [Related]  

  • 20. PRECIS-2 for retrospective assessment of RCTs in systematic reviews.
    Zwarenstein M; Thorpe K; Treweek S; Loudon K
    J Clin Epidemiol; 2020 Oct; 126():202-206. PubMed ID: 32565215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.